Rethinking Smoking in America
As someone with a background in medicine and public service, I’ve dedicated much of my life to improving health policies. I also have personal experience with the impact of smoking—having lost my father to what I call “Lucky Strike Lung.” This reality still weighs heavily on me and highlights that smoking is a significant, ongoing public health issue.
Nonetheless, there seems to be a disconnect in Washington. Smoking is often dismissed as a past problem, yet around 25 million American adults still smoke. Many of these individuals are excluded from current public health dialogues. A recent white paper titled “The Forgotten Smoker” from Philip Morris International (PMI) emphasizes this critical oversight: significant progress has stalled for millions who are still at high risk.
From a medical standpoint, these individuals are real people—patients, parents, coworkers, and veterans. Many have attempted to quit multiple times and fully comprehend the risks. But knowing the dangers and overcoming addiction are not the same thing. If we genuinely want to reduce smoking-related illnesses, our policies must consider the reality that many adults are still smoking, rather than hoping the problem will simply resolve itself.
A more effective strategy would center on the principle that combustion poses the highest level of harm. The FDA acknowledges a spectrum of risks associated with tobacco and nicotine products, indicating that cigarettes are the most harmful while smoke-free alternatives tend to carry fewer health risks. This is a vital point. Even for those unable to quit nicotine entirely, reducing cigarette use can still make a significant difference in health.
Sadly, that crucial message hasn’t reached everyone it should. The FDA could indeed facilitate progress by approving cessation products through thorough scientific evaluations, but this is almost pointless if patients are unaware or if clinicians lack the knowledge to discuss these options properly. As a physician, this is particularly troubling for me. Regulations matter, but communication is what translates those regulations into meaningful public health outcomes.
Data supports this view. A national survey of 1,565 healthcare professionals commissioned by PMI revealed that 47% mistakenly believe nicotine is a carcinogen, and an additional 19% were uncertain. In reality, nicotine itself does not cause cancer.
The same survey highlighted that 69% of clinicians want the FDA to disseminate clinical evidence regarding the benefit of cessation products in reducing harm, while 68% desire clear guidelines for counseling patients looking to reduce cigarette use. A staggering 95% said they would pass along any helpful information from the FDA to their patients. This indicates a significant need for reliable resources, and the FDA could fulfill that role effectively.
The issues extend beyond the clinic. Research indicates there’s a widespread misunderstanding about nicotine and its risks. For instance, 52% of Americans believe nicotine directly contributes to cancer, and 73% think that all tobacco products pose equal hazards.
However, Americans also realize there is still work to be done. When confronted with the persistent levels of smoking, 79% believe more should be done to mitigate the harms of smoking. In Washington, this should be viewed as both a warning and a call to action.
Going forward, the FDA needs to equip healthcare providers with practical, straightforward guidance that can be implemented immediately. This would involve creating a resource informed by experienced physicians that clarifies FDA approvals and outlines how to have evidence-based conversations with adult smokers wanting to transition away from cigarettes.
It’s crucial to emphasize that smoking, not nicotine, is what presents the most significant health risks. We must ensure that licensing information is comprehensible to non-specialists and effectively conveyed in clinical settings, where patient choices occur. Additionally, reaching out directly to adult smokers—particularly older individuals and veterans who represent a large segment of current smokers—is essential for effective communication.
Effective public health policy engages individuals where they are, utilizes the best available evidence, and equips both patients and clinicians with actionable tools. The ‘forgotten smoker’ has been overlooked for far too long. It’s time for Washington to pay attention and take meaningful action.
